RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity

NCT02529631 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: orlistat 60 mg
DEVICE: polyglucosamine

Sponsor

Certmedica International GmbH